Progress in understanding of role of high density lipoprotein, apolipoprotein A-I, and serum amyloid A in sepsis

doi:10.3877/cma.j.issn.1674-0785.2023.06.021

Abstract

Abstract:

High-density lipoprotein (HDL) can bind and neutralize the endotoxin of Gram-negative bacteria and lipoteichoic acid of Gram-positive bacteria through apolipoprotein A-I (ApoA-I) during sepsis. The expression of serum amyloid A (SAA) is significantly increased in sepsis, and ApoA-I in HDL is replaced by SAA, resulting in a significant reduction in plasma HDL levels, an independent risk factor for sepsis. HDL has dysfunction during sepsis, and the exact mechanism of SAA in altering HDL structure and function is not clear. This paper reviews the change trend of HDL, ApoA-I, and SAA during sepsis, the interaction between them, and the clinical application of various indexes, to provide a theoretical basis for the further study of lipoproteins and related apolipoproteins in sepsis.

Key words: Sepsis, High-density lipoprotein, Apolipoproteina-I, Serum amyloid A

Rui Tan, Jing Wang, Jiangquan Yu, Ruiqiang Zheng. Progress in understanding of role of high density lipoprotein, apolipoprotein A-I, and serum amyloid A in sepsis[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 749-753.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2023.06.021

https://zhlcyszz.cma-cmc.com.cn/EN/Y2023/V17/I06/749

References 64

1	Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
2	Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study [J]. Lancet, 2020, 395(10219): 200-211.
3	Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research [J]. Lancet Infect Dis, 2015, 15(5): 581-614.
4	Rudd KE, Delaney A, Finfer S. Counting Sepsis, an imprecise but improving science [J]. JAMA, 2017, 318(13): 1228-1229.
5	Klein Klouwenberg PM, Cremer OL, van Vught LA, et al. Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study [J]. Crit Care, 2015, 19(1): 319.
6	Kaysen GA, Ye X, Raimann JG, et al. Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results [J]. J Lipid Res, 2018, 59(8): 1519-1528.
7	Catapano AL, Pirillo A, Bonacina F, et al. HDL in innate and adaptive immunity [J]. Cardiovasc Res, 2014, 103(3): 372-383.
8	Cheng N, Liang Y, Du X, et al. Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury [J]. EMBO Rep, 2018, 19(10).
9	Holmes MV, Asselbergs FW, Palmer TM, et al. Mendelian randomization of blood lipids for coronary heart disease [J]. Eur Heart J, 2015, 36(9): 539-350.
10	Meilhac O, Tanaka S, Couret D. High-density lipoproteins are bug scavengers [J]. Biomolecules, 2020, 10(4).
11	Tanaka S, Labreuche J, Drumez E, et al. Low HDL levels in sepsis versus trauma patients in intensive care unit [J]. Ann Intensive Care, 2017, 7(1): 60.
12	Chien JY, Jerng JS, Yu CJ, et al. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis [J]. Crit Care Med, 2005, 33(8): 1688-1693.
13	Dai L, Datta G, Zhang Z, et al. The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats [J]. J Lipid Res, 2010, 51(9): 2695-2705.
14	De Nardo D, Labzin LI, Kono H, et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3 [J]. Nat Immunol, 2014, 15(2): 152-160.
15	Ye RD, Sun L. Emerging functions of serum amyloid A in inflammation [J]. J Leukoc Biol, 2015, 98(6): 923-929.
16	Chenaud C, Merlani PG, Roux-Lombard P, et al. Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation [J]. Crit Care Med, 2004, 32(3): 632-637.
17	Guirgis FW, Black LP, Henson M, et al. A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes [J]. Crit Care, 2021, 25(1): 341.
18	Morin EE, Guo L, Schwendeman A, et al. HDL in sepsis - risk factor and therapeutic approach [J]. Front Pharmacol, 2015, 6: 244.
19	Curcic S, Holzer M, Frei R, et al. Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL [J]. Biochim Biophys Acta, 2015, 1851(2): 184-193.
20	Duchateau PN, Pullinger CR, Orellana RE, et al. Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L [J]. J Biol Chem, 1997, 272(41): 25576-25582.
21	Henning MF, Herlax V, Bakás L. Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect [J]. Innate Immun, 2011, 17(3): 327-337.
22	Flegel WA, Baumstark MW, Weinstock C, et al. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I [J]. Infect Immun, 1993, 61 (12):5140-5146.
23	Humphries SE, Whittall RA, Hubbart CS, et al. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk [J]. J Med Genet, 2006, 43(12): 943-949.
24	Li Y, Dong JB, Wu MP. Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice [J]. Eur J Pharmacol, 2008, 590(1-3): 417-422.
25	Imai T, Fujita T, Yamazaki Y. Beneficial effects of apolipoprotein A-I on endotoxemia [J]. Surg Today, 2003, 33(9): 684-687.
26	Yan YJ, Li Y, Lou B, et al. Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice [J]. Life Sci, 2006,79(2): 210-215.
27	Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein [J]. Atherosclerosis, 1993, 102(2): 131-146.
28	Sack GHJr. Serum amyloid A - a review [J]. Mol Med, 2018, 24(1): 46.
29	Benditt EP, Eriksen N, Hanson RH. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein [J]. Proc Natl Acad Sci U S A, 1979, 76(8): 4092-4096.
30	Baltz ML, Rowe IF, Caspi D, et al. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils? [J]. Clin Exp Immunol, 1986, 66(3): 701-708.
31	Lee J, Beatty GL. Serum Amyloid A Proteins and Their Impact on Metastasis and Immune Biology in Cancer [J]. Cancers (Basel), 2021, 13(13).
32	Eklund KK, Niemi K, Kovanen PT. Immune functions of serum amyloid A [J]. Crit Rev Immunol, 2012, 32(4): 335-348.
33	Cetinkaya M, Ozkan H, Köksal N, et al. The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants [J]. Pediatr Surg Int, 2010, 26(8): 835-841.
34	Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant [J]. Eur J Biochem, 1999, 265(2): 501-523.
35	Shainkin-Kestenbaum R, Winikoff Y, Cristal N. Serum amyloid A concentrations during the course of acute ischaemic heart disease [J]. J Clin Pathol, 1986, 39(6): 635-637.
36	De Buck M, Gouwy M, Wang JM, et al. The cytokine-serum amyloid A-chemokine network [J]. Cytokine Growth Factor Rev, 2016, 30: 55-69.
37	Steel DM, Rogers JT, DeBeer MC, et al. Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly (A) tail shortening and translational efficiency [J]. Biochem J, 1993, 291 (Pt 3) (Pt 3): 701-707.
38	Mayer JM, Raraty M, Slavin J, et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis [J]. Br J Surg, 2002, 89(2): 163-171.
39	Rau B, Steinbach G, Baumgart K, et al. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant [J]. Crit Care Med, 2000, 28(3): 736-742.
40	Cetinkaya M, Ozkan H, Köksal N, et al. Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants [J]. J Pediatr Surg, 2011, 46(8): 1482-1489.
41	Liu C, Zhang Y, Shang Y, et al. Clinical values of common biomarkers for efficacy monitoring of antibiotics in early-onset neonatal sepsis [J]. Transl Pediatr, 2020, 9(5): 669-676.
42	Bengnér J, Quttineh M, Gäddlin PO, et al. Serum amyloid A - A prime candidate for identification of neonatal sepsis [J]. Clin Immunol, 2021,229: 108787.
43	Schuchardt M, Prüfer N, Tu Y, et al. Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells [J]. Sci Rep, 2019, 9(1): 3421.
44	Ather JL, Ckless K, Martin R, et al. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice [J]. J Immunol, 2011, 187(1): 64-73.
45	Migita K, Koga T, Satomura K, et al. Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts [J]. Arthritis Res Ther, 2012, 14(3): R119.
46	Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body [J]. Annu Rev Immunol, 2009, 27: 229-265.
47	Gouwy M, De Buck M, Pörtner N, et al. Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines [J]. Eur J Immunol, 2015, 45(1): 101-112.
48	Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age [J]. Nat Immunol, 2018, 19(2): 108-119.
49	Linke RP, Meinel A, Chalcroft JP, et al. Serum amyloid A (SAA) treatment enhances the recovery of aggravated polymicrobial sepsis in mice, whereas blocking SAA's invariant peptide results in early death [J]. Amyloid, 2017, 24(sup1): 149-150.
50	Gatt ME, Urieli-Shoval S, Preciado-Patt L, et al. Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils [J]. J Lab Clin Med, 1998, 132(5): 414-420.
51	Sun L, Zhou H, Zhu Z, et al. Ex vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils [J]. J Immunol, 2015, 194(10): 4891-4900.
52	Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes [J]. Cell, 2014, 157(5): 1013-1022.
53	Sander LE, Sackett SD, Dierssen U, et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function [J]. J Exp Med, 2010, 207(7): 1453-1464.
54	Newton K, Dixit VM. Signaling in innate immunity and inflammation [J]. Cold Spring Harb Perspect Biol, 2012, 4(3): a006049.
55	Annema W, Nijstad N, Tölle M, et al. Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2) [J]. J Lipid Res, 2010, 51(4): 743-754.
56	McGillicuddy FC, de la Llera Moya M, Hinkle CC, et al. Inflammation impairs reverse cholesterol transport in vivo [J]. Circulation, 2009, 119(8): 1135-1145.
57	Hu W, Abe-Dohmae S, Tsujita M, et al. Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo [J]. J Lipid Res, 2008, 49(2): 386-393.
58	Kisilevsky R, Manley PN. Acute-phase serum amyloid A: perspectives on its physiological and pathological roles [J]. Amyloid, 2012, 19(1): 5-14.
59	Karlsson H, Kontush A, James RW. Functionality of HDL: antioxidation and detoxifying effects [J]. Handb Exp Pharmacol, 2015, 224: 207-228.
60	Tölle M, Huang T, Schuchardt M, et al. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A [J]. Cardiovasc Res, 2012, 94(1): 154-162.
61	Jayaraman S, Haupt C, Gursky O. Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA [J]. J Lipid Res, 2016, 57(12): 2138-2149.
62	Sato M, Ohkawa R, Yoshimoto A, et al. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein [J]. Biosci Rep, 2016, 36(4): e00369.
63	Tsunoda F, Lamon-Fava S, Horvath KV, et al. Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins [J]. Lipids Health Dis, 2016, 15(1): 163.
64	Zheng A, Widmann C. The interplay between serum amyloid A and HDLs [J]. Curr Opin Lipidol, 2020, 31(5): 300-301.

[1]	Jianbiao Meng, Geng Zhang, Yanna Jiao. Exploratory study on early intestinal microecological changes in patients with sepsis-induced myocardial dysfunction [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2023, 16(04): 279-285.
[2]	Yu Chen, Fang Feng, Lu Zhang, Jian Liu. Bioinformatics analysis to screen key pathogenic genes in septic cardiomyopathy [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2023, 16(04): 286-291.
[3]	Yuanyuan Han, Sabeiti Reziya, Zhijie Mao, Aierken Mufunayi, Chen Lu, Xiaohong Sang, Mulati Aerman, Li Zhang. Effect of combined blood purification on serum inflammatory cytokines levels and clinical prognosis in patients with sepsis [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2023, 16(04): 272-278.
[4]	Xiaoyan Zhang, Dongqiong Xiao, Hu Gao, Lin Chen, Fajuan Tang, Xihong Li. The protective effect and mechanism of overexpression of transcription factor 12 on the cerebral cortex of rats with sepsis-associated encephalopathy [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 540-549.
[5]	Xu Wei, Ge Zhang, Jinlin Wu. Monitoring and treatment of neonatal sepsis-induced coagulopathy [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 379-386.
[6]	Xiaodan Wang, Yuan Wang, Xiangyu Cui, Xiaolei Ren. Analysis of pathogenic bacteria resistance of drug and high risk factors of death in urogenic sepsis after endoscopic surgery for upper urinary tract stones [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(06): 611-615.
[7]	Xuecheng Wu, Yuanwei Li, Wuxiong Yuan, Jiansong Wang, Yongzhong Shi, Qiang Lu, Zhuo Li, Jia Chen, Zhe Liu, Yili Teng, Zhiyong Gao. Diagnostic value of inflammatory mediators profile combined with procalcitonin in urogenic sepsis [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(05): 476-480.
[8]	Shangwen Dou, Huan Deng, Bangfeng Liu, Gaoyuanzhi Yue, Huacai Zhu, Yongda Liu. Role of preoperative urine culture re-examination in the prediction of infectious complications related to mini-percutaneous nephrolithotomy [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(04): 361-366.
[9]	Ruanxin Miao, Xi Qiao. Role of Toll-like receptor in sepsis-induced acute kidney injury [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(04): 210-214.
[10]	Shiming Li, Wei Huang, Ling Liu. Mechanism of high mobility group box protein 1 mediated sepsis-induced coagulopathy and treatment progress [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(03): 269-273.
[11]	Chao Gao, Jie Chao, Haibo Qiu. Emerging roles of transcription factor T-bet of Th17 in immune imbalance of sepsis [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(03): 280-285.
[12]	Xiang Yang, Lanqi Guo, Jianfeng Xie, Haibo Qiu. Role of metagenomics next-generation sequencing in the pathogen diagnosis in sepsis [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(03): 292-297.
[13]	Shaohong Zhuo, Xiuling Lin, Cuimei Zhou, Weilian Xiong, Xingzao Ma. Application value of CD64 index combined with serum SAA/CRP and PCT in the diagnosis of children with infectious gastrointestinal diseases [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 505-509.
[14]	Xing Cai, Ruiqiang Zheng. Progress in application of heparin-binding protein in sepsis [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 487-490.
[15]	Qiao Jiang, Zhenle Zhang, Yanling Zhang, Zhanpeng Yu. Construction and evaluation of risk prediction model of acute pancreatitis complicated with sepsis based on MIMIC-Ⅲ database [J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2023, 11(03): 151-157.

Please choose a citation manager

Content to export